NurExone Biologic Inc. (TSXV:NRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.6800
-0.0100 (-1.45%)
Mar 27, 2025, 4:00 PM EST
-12.82%
Market Cap 50.41M
Revenue (ttm) n/a
Net Income (ttm) -5.72M
Shares Out 74.14M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,000
Average Volume 56,819
Open 0.6800
Previous Close 0.6900
Day's Range 0.6800 - 0.6900
52-Week Range 0.4600 - 0.8700
Beta 0.16
RSI 55.92
Earnings Date Mar 28, 2025

About NurExone Biologic

NurExone Biologic Inc., operates as a pharmaceutical technology company. It is developing an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol NRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.